Table 1.
Clinical characteristics and demographics of the BD patients included in this study
| Characteristics | Combined | Patients taking lithium | Patients taking valproate | |||
|---|---|---|---|---|---|---|
| Responders | Non-responders | Responders | Non-responders | Responders | Non-responders | |
| Sample size (N) | 13 | 9 | 9 | 7 | 4 | 2 |
| Age (years) mean ± SD |
42.3 ± 10.6 | 50.9 ± 10.2 | 40.6 ± 11.1 | 50.6 ± 10.2 | 46.3 ± 9.5 | 52 ± 14.1 |
| Gender (% female) |
69.2 | 66.7 | 77.8 | 57.1 | 50 | 100 |
| Race (% Caucasian) |
100 | 88.9 | 100 | 85.7 | 100 | 100 |
| MADRS score at 230 min mean ± SD |
11 ± 4 | 29 ± 7 | 12 ± 4 | 28 ± 7 | 8 ± 5 | 32 ± 1 |
| Percentage reduction in MADRS mean ± SD |
67 ± 12 | 13 ± 13 | 64 ± 11 | 14 ± 15 | 75 ± 13 | 9 |
BD, bipolar depression; MADRS, Montgomery Åsberg Depression Rating Scale.